• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性膜性肾病成年患者完全缓解后的预后

Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy.

作者信息

Laluck B J, Cattran D C

机构信息

Department of Medicine, University of Toronto, Toronto, Canada.

出版信息

Am J Kidney Dis. 1999 Jun;33(6):1026-32. doi: 10.1016/S0272-6386(99)70138-1.

DOI:10.1016/S0272-6386(99)70138-1
PMID:10352189
Abstract

This review of the long-term outcome after a complete remission of proteinuria includes 82 adult patients with biopsy-proven idiopathic membranous glomerulonephritis (IMGN), who represented 25% of the total cases (82 of 323 cases) of IMGN in our registry. Complete remission was defined as at least two consecutive follow-up evaluations showing proteinuria of 0.3 g/d or less of protein. Before remission, 70% of the patients had nephrotic-range proteinuria (61% at presentation, 9% during follow-up), and 30% were always subnephrotic (protein level < 3.5 g/d). Mean total observation time was 101 +/- 56 months, with a postremission period of 69 +/- 60 months. Seventy-one percent of the patients remained in remission and 29% relapsed. In the relapse group, 46% relapsed to nephrotic-range proteinuria and 54% relapsed to subnephrotic levels. The plasma creatinine level remained stable in 86% of the patients (71 of 82 patients) but became or remained elevated despite a period of complete remission in the remaining 14% (8 of 82 patients). No patient went on to end-stage renal disease. Seventy-seven percent of the patients had no specific treatment within 6 months of remission, whereas 23% had steroid therapy alone or in combination with an immunosuppressive agent. In a multivariate analysis, the factors that favored both remission and its durability were persistent lower levels of proteinuria and female sex. Complete remission indicates an excellent long-term prognosis in patients with IMGN, but relapses are common and, in a small percentage, chronic renal insufficiency occurs. Thus, our data suggest that even this group of patients should be monitored on a regular basis.

摘要

本项关于蛋白尿完全缓解后的长期预后的综述纳入了82例经活检证实为特发性膜性肾小球肾炎(IMGN)的成年患者,这些患者占我们登记的IMGN总病例数(323例中的82例)的25%。完全缓解定义为至少两次连续的随访评估显示蛋白尿≤0.3g/d。缓解前,70%的患者有肾病范围蛋白尿(初诊时61%,随访期间9%),30%的患者蛋白尿始终低于肾病范围(蛋白水平<3.5g/d)。平均总观察时间为101±56个月,缓解期为69±60个月。71%的患者保持缓解,29%复发。在复发组中,46%复发至肾病范围蛋白尿,54%复发至低于肾病范围水平。86%的患者(82例中的71例)血浆肌酐水平保持稳定,但其余14%(82例中的8例)患者尽管有一段时间完全缓解,肌酐水平仍升高或持续升高。无患者进展至终末期肾病。77%的患者在缓解后6个月内未接受特殊治疗,而23%的患者仅接受了类固醇治疗或联合免疫抑制剂治疗。多因素分析显示,有利于缓解及其持续性的因素是蛋白尿持续处于较低水平和女性性别。完全缓解表明IMGN患者长期预后良好,但复发常见,且有小部分患者会发生慢性肾功能不全。因此,我们的数据表明,即使是这组患者也应定期监测。

相似文献

1
Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy.特发性膜性肾病成年患者完全缓解后的预后
Am J Kidney Dis. 1999 Jun;33(6):1026-32. doi: 10.1016/S0272-6386(99)70138-1.
2
Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria.膜性肾病患者蛋白尿完全缓解后的长期预后
Nephrol Dial Transplant. 1989;4(6):525-9.
3
Prognosis of untreated patients with idiopathic membranous nephropathy.未经治疗的特发性膜性肾病患者的预后。
N Engl J Med. 1993 Jul 8;329(2):85-9. doi: 10.1056/NEJM199307083290203.
4
Remissions and relapses in idiopathic membranous nephropathy.特发性膜性肾病的缓解与复发
Nephrol Dial Transplant. 1992;7 Suppl 1:85-90.
5
Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment.膜性肾病伴慢性肾功能不全的肾病综合征自发缓解。
Nephrol Dial Transplant. 2012 Jan;27(1):231-4. doi: 10.1093/ndt/gfr285. Epub 2011 May 30.
6
Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.膜性肾病和肾功能不全的细胞毒性治疗:改善肾脏存活率但复发率高。
Nephrol Dial Transplant. 2004 May;19(5):1142-8. doi: 10.1093/ndt/gfh036. Epub 2004 Feb 19.
7
Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.膜性肾病的临床和形态学预后因素:局灶节段性肾小球硬化的意义
Am J Kidney Dis. 2003 Jan;41(1):38-48. doi: 10.1053/ajkd.2003.50015.
8
Effectiveness of steroid therapy in different stages of membranous nephropathy.类固醇疗法在膜性肾病不同阶段的疗效
Nephrol Dial Transplant. 1989;4(12):1022-9.
9
[Membranous glomerulonephritis].[膜性肾小球肾炎]
Srp Arh Celok Lek. 1996;124 Suppl 1:18-25.
10
Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency.特发性膜性肾病合并肾功能不全患者尿中高分子量和低分子量蛋白质排泄的治疗相关变化。
Nephrol Dial Transplant. 2006 Feb;21(2):389-96. doi: 10.1093/ndt/gfi219. Epub 2005 Oct 18.

引用本文的文献

1
Syphilis and nephrotic syndrome: A case report and literature review.梅毒与肾病综合征:一例病例报告及文献综述
IDCases. 2024 Jun 28;37:e02016. doi: 10.1016/j.idcr.2024.e02016. eCollection 2024.
2
Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage.特发性膜性肾病伴肾小管间质性损害患者的临床特征和预后。
Ren Fail. 2023 Dec;45(1):2205951. doi: 10.1080/0886022X.2023.2205951.
3
The thickness of glomerular basement membrane predicts complete remission in primary membranous nephropathy.
肾小球基底膜厚度可预测原发性膜性肾病的完全缓解。
Ren Fail. 2023 Dec;45(1):2179335. doi: 10.1080/0886022X.2023.2179335.
4
Substitution of Oral for Intravenous Cyclophosphamide in Membranous Nephropathy.口服环磷酰胺替代静脉注射环磷酰胺治疗膜性肾病。
Kidney360. 2020 Aug 7;1(9):943-949. doi: 10.34067/KID.0002802020. eCollection 2020 Sep 24.
5
Use of Rituximab as an Off-Label Medication in Glomerular Diseases: Clinical Perspective.利妥昔单抗在肾小球疾病中的超适应证用药:临床视角。
Med Princ Pract. 2022;31(2):133-141. doi: 10.1159/000521901. Epub 2022 Jan 12.
6
Tacrolimus versus cyclophosphamide for patients with idiopathic membranous nephropathy and treated with steroids: a systematic review and meta-analysis of randomized controlled trials.他克莫司与环磷酰胺治疗激素治疗的特发性膜性肾病患者的随机对照试验的系统评价和荟萃分析。
Ren Fail. 2021 Dec;43(1):840-850. doi: 10.1080/0886022X.2021.1914655.
7
Relapse of membranous nephropathy with cancer immunotherapy.癌症免疫疗法导致的膜性肾病复发
Clin Kidney J. 2019 Jun 21;14(1):418-420. doi: 10.1093/ckj/sfz074. eCollection 2021 Jan.
8
Idiopathic membranous nephropathy in older patients: Clinical features and outcomes.特发性膜性肾病在老年患者中的临床特征和结局。
PLoS One. 2020 Oct 9;15(10):e0240566. doi: 10.1371/journal.pone.0240566. eCollection 2020.
9
Clinical and pathological features of idiopathic membranous nephropathy with focal segmental sclerosis.特发性膜性肾病伴局灶节段性肾小球硬化的临床和病理特征。
BMC Nephrol. 2019 Dec 16;20(1):467. doi: 10.1186/s12882-019-1641-2.
10
Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan.特发性膜性肾病患者的尿蛋白与肾脏预后:日本多中心回顾性队列研究。
Ren Fail. 2018 Nov;40(1):435-441. doi: 10.1080/0886022X.2018.1487864.